Borofalan (10B)

N/A

Report date: 2026/04/14 20:00:15
NMEFirst In Class

Base Information

Drug NameBorofalan (10B)
Drug Alias NameBoronophenylalanine硼[10B]法仑Para-BoronophenylalanineSteboronineステボロニン +[9] 
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Boron
Mechanisms of ActionBoron neutron capture therapy
TargetsNot applicable
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsHead and Neck Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2020/03/25
Country/TerritoryFinlandJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesStella PharmaOsaka University
China Registration ClassN/A

Develop Information

Active CompaniesStella Pharma CoNeutron Therapeutics LLCTAE Life Sciences
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01XX
Related LinksKEGG